8-KOther EventsExhibits & Filings

Medtronic plc 8-K Report, Corporate Update (Aug 5, 2015)

Filed August 5, 2015For Securities:MDT

Summary

Medtronic plc (MDT) filed an 8-K on August 4, 2015, to announce the commencement of several exchange offers for its outstanding senior notes. These offers involve exchanging existing notes issued by Medtronic, Inc., and guaranteed by Medtronic plc and Medtronic Global Holdings S.C.A., for newly issued, registered notes with substantially identical terms. This move is primarily driven by the need to comply with regulations following the company's recent inversion merger, aiming to align its debt structure with its new Irish domicile and potentially simplify its financial operations and reporting for investors. The exchange offers cover a significant principal amount across various maturity dates, ranging from 2020 to 2045, totaling up to $19.5 billion. The offers are designed to remove transfer restrictions and registration rights associated with the original notes, making the new exchange notes more liquid and attractive to a broader investor base. The exchange period runs from August 4, 2015, to August 31, 2015, indicating a clear timeframe for noteholders to participate.

Key Highlights

  • 1Medtronic announced exchange offers for up to $19.5 billion in aggregate principal amount of its outstanding senior notes.
  • 2The exchange involves replacing existing notes issued by Medtronic, Inc. with newly registered notes guaranteed by Medtronic plc and Medtronic Global Holdings S.C.A.
  • 3The primary purpose is to register the debt securities under Medtronic plc's new corporate structure following its incorporation in Ireland.
  • 4The terms of the exchange notes are substantially identical to the original notes, except for registration, transfer restrictions, and additional interest provisions.
  • 5The exchange offers commence on August 4, 2015, and will expire on August 31, 2015.
  • 6This action is a standard procedure to streamline debt management and comply with regulatory requirements post-corporate inversion.

Frequently Asked Questions

The main purpose of these exchange offers is to register Medtronic's outstanding debt securities with its new corporate domicile in Ireland. Following the inversion transaction, the company is exchanging older notes, which may have transfer restrictions and registration rights tied to their prior structure, for new, registered notes with substantially identical terms but without these restrictions.

Medtronic is offering to exchange up to a total of $19.5 billion in aggregate principal amount of outstanding senior notes. These include Floating Rate Senior Notes due March 15, 2020, and fixed-rate notes maturing in 2018, 2020, 2022, 2025, 2035, and 2045.

The exchange notes will have terms substantially identical to the original notes. The key differences are that the exchange notes will be registered under the Securities Act, meaning they will not have the same transfer restrictions and registration rights as the original notes. Additionally, provisions for additional interest applicable to the original notes will not apply to the exchange notes.

The exchange offers commenced on August 4, 2015, and will expire at 11:59 p.m., New York City time, on August 31, 2015. Noteholders must tender their original notes before this deadline to receive the new exchange notes.